The incidence of meningioma increases with advancing age, with the median age of diagnosis being about 65 years. There are some factors associated with faster progression of the tumor, they include absence of calcification, age 60 or younger, and intial tumor diameter greater than 25mm. Meningiomas can grow in a linear or volumetric fashion. They can grow anywhere in the central nervous system containing arachnoid membrane. If left untreated, patients with meningioma may progress to developing morning headaches, focal neurological deficits, edema surrounding the tumor, cranial nerve palsies, and more. Prognosis is generally good, and the survival rate of patients with meningioma mainly depends on the grade and the extent of resection of the tumor.
Natural History, Complications, and Prognosis[edit | edit source]
The median age at diagnosis of meningioma is about 65 years, with incidence increasing with advancing age.[1]
Absence of calcification, age 60 or younger, and initial tumor diameter of greater than 25 mm are among the factors associated with a short time to progression.[2]
Linear growth may be seen in 44% of the patients, while volumetric growth may be seen in 74%.[2]
A higher annual growth rate may be seen in patients with an initial tumor diameter of greater than 25 mm, MR imaging T2 signal hyperintensity, patients presenting with symptoms and edema, and male patients.[2]
Meningomas are usually single but can be multiple in about 1 - 10% of the patients. Multiple meningiomas are usually seen in patients with neurofibromatosis.[3][4]
The rate of growth in patients with multiple meningiomas is similar to those with solitary meningiomas.
The prognosis of meningioma is usually determined by 2 of the most important factors which are the extent of the resection and the histological grade of the tumor.[8]
Patients with atypical meningioma have a higher overall recurrence-free survival rate than those with anaplastic meningioma.[9]
The prognostic factors in patients with anaplastic meningioma include brain invasion, adjuvant radiotherapy, malignant progression, p53 over expression, and extent of resection.[9]
There may be a chance of recurrence of higher grade meningiomas even if they received gross-total resection or not.[8]
Grade 1 meningioma is associated with a median survival of approximately 10 years.[10]
Grade 3 meningioma is associated with a median survival of approximately 2.7 years.
For classic tumors, the 5 year recurrence rate is about 12%, and they are not associated with a decreased overall length of survival. Unlike atypical tumors which have a 41% recurrence rate and decreased overall length of survival.[8]
↑Komotar, R J (2003). "Meningioma presenting as stroke: report of two cases and estimation of incidence". Journal of Neurology, Neurosurgery & Psychiatry. 74 (1): 136–137. doi:10.1136/jnnp.74.1.136. ISSN0022-3050.
↑ 8.08.18.28.3Commins, Deborah L.; Atkinson, Roscoe D.; Burnett, Margaret E. (2007). "Review of meningioma histopathology". Neurosurgical Focus. 23 (4): E3. doi:10.3171/FOC-07/10/E3. ISSN1092-0684.